US20230082397A1
(en )
2023-03-16
Acetaminophen compound composition without side effect to liver
EP3991724B1
(en )
2025-07-16
Mannitol for use in treating hepatotoxicity and fatty liver diseases
KR20170095894A
(ko )
2017-08-23
암모니아-저감 치료를 이용한 간성상세포 활성화와 연관된 질병의 치료
CN102802418A
(zh )
2012-11-28
用于治疗肌萎缩性侧索硬化的组合物和方法
US8969312B2
(en )
2015-03-03
Low side effect pharmaceutical composition containing antituberculosis drugs
EP4406540A1
(en )
2024-07-31
Composition for treating coronavirus disease 2019 (covid-19) containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof and antiviral agent as active ingredients
EP4461304A1
(en )
2024-11-13
Composition for preventing or improving hepatic dysfunction
HK40085737A
(zh )
2023-08-11
无肝副作用的对乙酰胺基酚新复方组合
Fornstedt-Wallin et al.
1999
3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3, 4-dioxygenase inhibitor NCR-631
AU2019220062B2
(en )
2024-11-14
Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (APAP)
HK1228775A1
(zh )
2017-11-10
无肝副作用的对乙酰胺基酚新复方组合
HK1228775B
(zh )
2022-12-16
无肝副作用的对乙酰胺基酚新复方组合
TWI552748B
(zh )
2016-10-11
The use of a compound for the removal of hepatotoxicity against Acetaminophen (APAP)
CN117462538A
(zh )
2024-01-30
黄酮类化合物在心肌缺血再灌注损伤中的应用
TWI666013B
(zh )
2019-07-21
一種化合物用於去除乙醯胺基酚(Acetaminophen，APAP)藥物肝毒性之用途
CN114886885A
(zh )
2022-08-12
一种具有抑制糖异生作用的药物组合物及其应用
JP6858729B2
(ja )
2021-04-14
肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
TW201236678A
(en )
2012-09-16
New non/low side-effect pharmaceutical composition of anti-tuberculosis drugs
KR100709531B1
(ko )
2007-04-23
당뇨병성 합병증의 예방 또는 진전저지용 의약조성물
CN101203229A
(zh )
2008-06-18
用于治疗或预防由肺泡破坏引起的肺病的克拉霉素或其盐
WO2025075711A1
(en )
2025-04-10
Methods and materials for treating hyperoxalemia and/or hyperoxaluria
JP2000095695A
(ja )
2000-04-04
精神分裂病治療薬